340 related articles for article (PubMed ID: 29199461)
1. Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.
Wilson JL; Altman RB
Exp Biol Med (Maywood); 2018 Feb; 243(3):313-322. PubMed ID: 29199461
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
3. Cancer Biomarker Discovery for Precision Medicine: New Progress.
Zou J; Wang E
Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
[TBL] [Abstract][Full Text] [Related]
4. Leveraging big data to transform target selection and drug discovery.
Chen B; Butte AJ
Clin Pharmacol Ther; 2016 Mar; 99(3):285-97. PubMed ID: 26659699
[TBL] [Abstract][Full Text] [Related]
5. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
Wu AC; Kiley JP; Noel PJ; Amur S; Burchard EG; Clancy JP; Galanter J; Inada M; Jones TK; Kropski JA; Loyd JE; Nogee LM; Raby BA; Rogers AJ; Schwartz DA; Sin DD; Spira A; Weiss ST; Young LR; Himes BE
Am J Respir Crit Care Med; 2018 Dec; 198(12):e116-e136. PubMed ID: 30640517
[TBL] [Abstract][Full Text] [Related]
6. Integrative methods for analyzing big data in precision medicine.
Gligorijević V; Malod-Dognin N; Pržulj N
Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence in early drug discovery enabling precision medicine.
Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
[No Abstract] [Full Text] [Related]
8. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
[TBL] [Abstract][Full Text] [Related]
9. Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tagliaferri P; Arbitrio M
Methods Mol Biol; 2022; 2401():1-12. PubMed ID: 34902118
[TBL] [Abstract][Full Text] [Related]
10. Advancing cancer drug development through precision medicine and innovative designs.
Zhang W; Wang J; Menon S
J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
[TBL] [Abstract][Full Text] [Related]
11. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations.
Thomford NE; Dzobo K; Chimusa E; Andrae-Marobela K; Chirikure S; Wonkam A; Dandara C
OMICS; 2018 Jun; 22(6):375-391. PubMed ID: 29927715
[TBL] [Abstract][Full Text] [Related]
12. Overcoming implementation challenges of personalized cancer therapy.
Meric-Bernstam F; Mills GB
Nat Rev Clin Oncol; 2012 Sep; 9(9):542-8. PubMed ID: 22850751
[TBL] [Abstract][Full Text] [Related]
13. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine for suicidality: from universality to subtypes and personalization.
Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome modeling and phenotypic assays for cancer precision medicine.
Jeong E; Moon SU; Song M; Yoon S
Arch Pharm Res; 2017 Aug; 40(8):906-914. PubMed ID: 28766239
[TBL] [Abstract][Full Text] [Related]
16. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
18. Exploiting microRNA Specificity and Selectivity: Paving a Sustainable Path Towards Precision Medicine.
Santulli G
Adv Exp Med Biol; 2015; 888():1-3. PubMed ID: 26663175
[TBL] [Abstract][Full Text] [Related]
19. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.
Alymani NA; Smith MD; Williams DJ; Petty RD
Eur J Cancer; 2010 Mar; 46(5):869-79. PubMed ID: 20138504
[TBL] [Abstract][Full Text] [Related]
20. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
